Analyst Ratings For NASDAQ:IMMU – Immunomedics (NASDAQ:IMMU)
Today, Wells Fargo & Co raised its price target on NASDAQ:IMMU – Immunomedics (NASDAQ:IMMU) to per share.
Some recent analyst ratings include
- 7/24/2017-Cowen Reiterated Rating of Outperform.
Recent Insider Trading Activity For NASDAQ:IMMU – Immunomedics (NASDAQ:IMMU)
NASDAQ:IMMU – Immunomedics (NASDAQ:IMMU) has insider ownership of 14.80% and institutional ownership of 74.28%.
- On 3/7/2018 David M Goldenberg, Director, sold 20,000 with an average share price of $17.50 per share and the total transaction amounting to $350,000.00.
- On 3/5/2018 David M Goldenberg, Director, sold 40,000 with an average share price of $17.24 per share and the total transaction amounting to $689,600.00.
- On 2/28/2018 David M Goldenberg, Director, sold 17,729 with an average share price of $17.09 per share and the total transaction amounting to $302,988.61.
- On 11/20/2017 Brian A Markison, Director, sold 8,390 with an average share price of $11.89 per share and the total transaction amounting to $99,757.10.
- On 11/15/2017 Behzad Aghazadeh, Insider, bought 1,325,000 with an average share price of $10.47 per share and the total transaction amounting to $13,872,750.00.
- On 11/14/2017 Venbio Select Advisor Llc, Director, bought 1,150,000 with an average share price of $10.39 per share and the total transaction amounting to $11,948,500.00.
- On 9/1/2017 David M. Goldenberg, Insider, sold 20,000 with an average share price of $12.64 per share and the total transaction amounting to $252,800.00.
Recent Trading Activity for NASDAQ:IMMU – Immunomedics (NASDAQ:IMMU)
Shares of NASDAQ:IMMU – Immunomedics closed the previous trading session at 25.64 up +2.93 12.89% with shares trading hands.